* Peregrine pharmaceuticals announces reverse stock split

* Peregrine pharmaceuticals -previously approved 1-for-7 reverse split of its outstanding shares of common stock will take effect on july 7, 2017

* Peregrine pharmaceuticals -common stock will open for trading on nasdaq capital market on july 10, on a split-adjusted basis Source text for Eikon: Further company coverage: